Palmetto General Hospital now offers Monoclonal Antibody Infusion for COVID-19. Approved for emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA), these investigational therapies are specifically for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients with positive COVID-19 test results who are at high risk for progressing to severe COVID-19 and/or hospitalization.
The two types of treatment therapies available are as follows:
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. In a clinical trial of patients with COVID-19, the infusion therapy – compared to placebo – was shown to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for progression of the disease within 28 days after treatment.
The infusions are administered by intravenous (IV) infusion directly into your bloodstream as a single combination dose. The procedure takes about two and a half hours.
Who Qualifies for Monoclonal Antibody Infusion?
Monoclonal antibody therapy is authorized for patients who have tested positive for COVID-19 and are
12 years of age or older
Weigh at least 88 pounds
Are at high risk for progressing to severe COVID-19 and/or hospitalization
Monoclonal Antibody Infusion is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19.
What Is Emergency Use Authorization (EUA)?
In certain types of emergencies, the FDA can issue an emergency use authorization, or EUA, to provide more timely access to critical medical products (including medicines and tests) that may help during the emergency when there are no adequate, approved and available alternative options.
How Do I Get Monoclonal Antibody Infusion?
To get the infusion treatment, you must be screened by your health care provider to make sure you meet the requirements and get a referral to make an appointment, or you can come to the Emergency Room at Palmetto General Hospital to coordinate arrangements for the treatment if you test positive for COVID 19 and the ER physician determines you meet criteria for treatment.